Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing blood loss in older patients with hip fracture
2024-519349-31-00Phase 4Completed
- Sponsor
- Biogipuzkoa Health Research Institute
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in hip fracture (2 arms), sponsored by Biogipuzkoa Health Research Institute. Primary endpoint: Blood transfusion rate. Started May 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on 2024-519349-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519349-31-00.